People who reach 110 years of age, known as supercentenarians, are exceptionally rare. A new immune-cell study reports that they also carry an unusual abundance of CD4 cytotoxic T cells. These cells appear to expand around age 100 and remain capable of varied responses, but the findings do not show that they cause exceptional longevity or prevent cancer.
Evidence at a glance
- Study type: Human observational single-cell immune profiling with integration of public datasets.
- Population: A small group of Japanese centenarians and supercentenarians, supplemented with public data spanning about 1,500 people from infancy into extreme old age.
- Evidence level: Exploratory human cellular evidence.
- Main caution: Extremely old participants are rare, so the directly studied group was small and may not represent all people who reach advanced ages.
Why these T cells are unusual
Most CD4 T cells act as coordinators. They help other immune cells recognize and respond to threats. Cytotoxic T cells can directly kill infected or abnormal cells, a role more commonly associated with CD8 T cells. CD4 cytotoxic T lymphocytes, or CD4 CTLs, combine the CD4 identity with cell-killing machinery.
Earlier work had already reported an expansion of these cells in supercentenarians. The new study examined their age pattern and molecular features in greater detail.
Expansion near the century mark
By combining single-cell profiles from exceptionally old participants with public immune datasets across the lifespan, the researchers concluded that CD4 CTLs begin to expand around age 100. The cells showed sequential loss of the surface markers CD27 and CD28, a pattern consistent with repeated immune stimulation and advanced differentiation.
Importantly, the cells did not display a simple signature of exhaustion. Immune exhaustion can occur after prolonged stimulation and can reduce a T cell’s ability to respond. The apparent persistence of active, specialized clones suggests that some very old immune systems may reorganize rather than merely decline.
Evidence of clonal expansion
T cells carry receptors with distinctive sequences that allow them to recognize particular targets. When many cells share the same receptor sequence, it indicates that a clone has expanded, usually after repeated recognition of an antigen.
The CD4 CTL population was dominated by large clones. The top clones averaged 33.3 percent of the cells examined in that population. Laboratory stimulation also showed subgroups with different interleukin expression patterns, suggesting that cells within a clone retained some functional flexibility.
A possible link to tumor recognition
Some of the leading receptor sequences resembled sequences previously observed in T cells expanded in tumors, particularly lung cancer. That similarity is intriguing because immune surveillance against abnormal cells could matter during a very long life.
It is not proof of cancer protection. A similar receptor sequence does not by itself identify the exact antigen being recognized, and the study did not experimentally show that these cells prevented tumors in supercentenarians.
Cause, consequence or survivor feature?
The study observed people who had already survived to extraordinary ages. Their CD4 CTLs could contribute to that survival, arise in response to decades of infection or antigen exposure, or reflect another feature shared by a highly selected group. These possibilities cannot be separated by an observational snapshot.
The direct cohort was necessarily small, and the participants were Japanese. Larger international studies, repeated sampling over time and experiments identifying the cells’ actual targets would strengthen the evidence.
The Lifespan Brief assessment
The findings add a useful idea to the study of immune aging. Exceptional longevity may involve selective immune remodeling, not simply preservation of a young immune system. CD4 cytotoxic T cells are a credible clue, but they are not yet a demonstrated mechanism of longevity or a treatment target.
Primary source
Hashimoto and colleagues, CD4 CTLs in supercentenarians: Signs of adaptive expansion in healthy aging, Cell Reports, published August 19, 2026.